Lipid Metabolism in Diabetic Kidney Disease

Diabetic kidney disease is characterised by progressive albuminuria, declining glomerular filtration and eventual renal failure, underpinned by profound disturbances in lipid handling. In healthy kidneys, fatty acids serve as a principal energy source for proximal tubular cells, undergoing uptake via specialised transporters and subsequent mitochondrial β-oxidation to generate ATP. Chronic hyperglycaemia and insulin resistance in diabetes shift this balance towards enhanced de novo lipogenesis, impaired fatty acid oxidation and increased lipid uptake. The resultant ectopic lipid deposition within glomerular and tubular compartments triggers lipotoxic injury through oxidative stress, inflammation and mitochondrial dysfunction. These processes culminate in mesangial expansion, podocyte injury, tubular cell apoptosis and interstitial fibrosis. Efforts to elucidate the molecular regulators of lipid flux in the diabetic kidney have opened new avenues for biomarkers and targeted interventions that aim to restore lipid homeostasis and preserve renal function.

Research from Nature Portfolio

Recent studies have revealed that long-term administration of lipid-lowering statins in diabetic experimental models may paradoxically exacerbate kidney injury by disrupting insulin signalling and lipid homeostasis. Chronic statin treatment was shown to activate PI3K–AKT–mTOR pathways, promoting fatty acid synthesis while simultaneously increasing lipid uptake and inhibiting fatty acid oxidation, thereby driving ectopic fat accumulation in renal tissues. This lipid overload intensified inflammation and interstitial fibrosis, accelerating the decline in renal function. These findings underscore the complexity of systemic lipid-lowering strategies in diabetes and the need to balance cardiovascular benefits against potential renal lipotoxicity.

Lipid Metabolism in Diabetic Kidney Disease publication trend

The graph below shows the total number of articles in lipid metabolism in diabetic kidney disease across all publications each year (not limited to Nature Index journals).

Technical terms

Ectopic fat deposition: Accumulation of lipid droplets in non-adipose tissues such as glomeruli and tubules, impairing cell function.

Fatty acid oxidation (FAO): Mitochondrial process of breaking down fatty acids to produce energy in the form of ATP.

De novo lipogenesis (DNL): Metabolic pathway synthesising fatty acids from acetyl-CoA and other precursors.

Lipotoxicity: Cellular injury and organ dysfunction caused by excessive lipid accumulation and associated oxidative stress.

Pyroptosis: Inflammatory form of programmed cell death triggered by inflammasome activation and gasdermin pore formation.

References

1. Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice. Nature Communications (2023).
2. MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity. Theranostics (2024).
3. ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. Journal of Clinical Investigation (2023).